GHD
Showing 1 - 25 of 183
Pediatric Growth Hormone Deficiency, Growth Disorders Trial in Sapporo (Somavaratan (VRS-317))
Terminated
- Pediatric Growth Hormone Deficiency
- Growth Disorders
- Somavaratan (VRS-317)
-
Sapporo, JapanHokkaido University Hospital
Jul 22, 2022
Gestational Hypertension, Cardiovascular Pregnancy Complication Trial in Diepenbeek (supervised infrared exercise group,
Recruiting
- Gestational Hypertension
- Cardiovascular Pregnancy Complication
- supervised infrared exercise group
- +2 more
-
Diepenbeek, Limburg, BelgiumHasselt University
May 25, 2023
IGHD - Isolated Growth Hormone Deficiency, Growth Retardation Trial in Petach-Tikva (Nutritional supplementation standardized
Recruiting
- IGHD - Isolated Growth Hormone Deficiency
- Growth Retardation
- Nutritional supplementation standardized formula
- Placebo
-
Petach-Tikva, IsraelSchnider children's medical center
Feb 21, 2022
Sogroya® in Short Stature Due to Growth Hormone Deficiency Where
Recruiting
- Growth Hormone Deficiency in Children
-
Tokyo, JapanNovo Nordisk Investigational Site
Oct 25, 2023
Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Recruiting
- Growth Hormone Deficiency
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 17, 2021
Growth Hormone Deficiency (GHD) Trial in Worldwide (MOD-4023)
Active, not recruiting
- Growth Hormone Deficiency (GHD)
-
Jacksonville, Florida
- +12 more
Apr 18, 2022
Discontinuation in Adults on Metabolic Profile, Body Composition
Recruiting
- Adult Growth Hormone Deficiency
- Dual energy X-ray absorptiometry (DXA)
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham NHS Foundation Trust
Jul 28, 2023
Impact of GH Measurements on GHD Diagnosis
Completed
- Growth Hormone Deficiency
- GH provocation tst
-
Montpellier, FranceUhmontpellier
Aug 12, 2020
Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases Trial in Worldwide (Once weekly
Completed
- Growth Hormone Deficiency, Pediatric
- +4 more
- Once weekly subcutaneous injection of TransCon hGH
- Once daily subcutaneous injection of Genotropin
-
Birmingham, Alabama
- +52 more
Dec 6, 2021
Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)
Completed
- Growth Hormone Deficiency, Pediatric
- +3 more
- TransCon hGH
-
Birmingham, Alabama
- +23 more
Dec 7, 2021
PEGylated GH for Treatment of Short Stature in Chinese
Recruiting
- Growth Hormone Treatment
- Growth Disorders
- Polyethylene glycol recombinant human growth hormone injection
-
Beijing, Beijing, ChinaDepartment of Endocrinology, Genetics, Metabolism
Sep 12, 2023
Ngenla Subcutaneous Injection Special Investigation
Not yet recruiting
- Growth Hormone Deficiency Without Epiphyseal Closure
- NGENLA (Somatrogon)
- (no location specified)
Dec 7, 2022
Adaption and Testing of Quality of Life in Short Stature Youth
Recruiting
- Achondroplasia
- +2 more
- Questionnaire
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Oct 28, 2022
Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)
Active, not recruiting
- Growth Hormone Deficiency, Pediatric
- +3 more
- TransCon hGH
-
Birmingham, Alabama
- +41 more
Oct 13, 2021
Growth Hormone Deficiency Trial in Worldwide (Genotropin, somatrogon)
Completed
- Growth Hormone Deficiency
-
Sacramento, California
- +31 more
Oct 12, 2021
DLBCL Refractory, Diffuse Large B-cell Lymphoma Recurrent Trial in Worldwide (Loncastuximab tesirine)
Completed
- Diffuse Large B-Cell Lymphoma Refractory
- Diffuse Large B-cell Lymphoma Recurrent
- Loncastuximab tesirine
-
Duarte, California
- +36 more
Aug 18, 2022
Prader-Willi Syndrome, Growth Hormone Deficiency Trial in France (Growth hormone (Genotonorm® or Omnitrope®), DEXA, blood tests,
Completed
- Prader-Willi Syndrome
- Growth Hormone Deficiency
- Growth hormone (Genotonorm® or Omnitrope®)
- +2 more
-
Amiens, France
- +25 more
Sep 17, 2021
Growth Hormone Deficiency Trial in Worldwide (LUM-201, rhGH Norditropin® pen (34 µg/kg))
Recruiting
- Growth Hormone Deficiency
- LUM-201
- rhGH Norditropin® pen (34 µg/kg)
-
Birmingham, Alabama
- +52 more
Jan 30, 2023
Growth Hormone Deficiency Trial in Charlottesville (LUM-201)
Enrolling by invitation
- Growth Hormone Deficiency
-
Charlottesville, VirginiaUniversity of Virginia Health System
Mar 9, 2022
Quality of Life, Clinical Response and Safety of Daily and
Recruiting
- Growth Hormone Deficiency
- Growth Hormone Treatment
- Long-Acting Growth Hormone (LAGH)
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 29, 2022